Brief

"On June 27, 2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Clinical study on the Touchcare insulin pump in a hybrid closed loop promoted by the company Medtrum: suspension of the inclusion of new patients. This decision was made due to non-compliance with regulations related to the reporting of adverse events, including severe cases of hyperglycemia and hypoglycemia that were not reported by the manufacturer."

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies